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Abstract 
Contrast-induced nephropathy (CIN) is a serious complication in patients with chronic kidney 
disease with coronary artery disease who undergo percutaneous coronary intervention (PCI), 
and is associated with higher morbidity and mortality in short and long term. The limiting 
volume of contrast agent is safest and most reliable strategy to prevent CIN. Here, we report a 
case of successful PCI using only 13 mL of contrast (iodixanol) of mid left anterior 
descending artery where wire in diagonal branch served as a landmark in a 75-year-old 
diabetic and hypertensive male who had presented with acute coronary syndrome and had 
marked renal dysfunction  having serum creatinine of 2.9 mg%. There was no change in basal 
renal function after the procedural and safely discharged.  
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Introduction 
Contrast-induced nephropathy (CIN) is associated with increased morbidity and mortality 
including the need for renal replacement therapy (RRT) which is defined as absolute (≥ 0.5 
mg/dL) or relative increase (≥ 25%) of serum creatinine from baseline after 48–72 hours 
following contrast administration, when alterative explanations have been excluded [1, 2].  
Peri-procedural hydration and minimum possible volume of contrast are the only established 
measures to prevent CIN [1, 3]. The risk of CIN which is 0.6–2.3% in general population and 
approaching to 20% in high risk patients, and requirement of RRT are the prime factors 
responsible for underutilization of percutaneous coronary intervention (PCI) in patients with 
established chronic kidney disease or those with baseline renal impairment [4].  
 
Case report 
 A 75-year-old diabetic and hypertensive male presented with chest heaviness with sweating 
of 6 hours duration. An electrocardiogram showed marked ST depression in V1–V4. Routine 
haemogram and biochemistry was normal except for high troponin I, and deranged renal 
function with serum creatinine of 2.9 mg%. His body weight was 68 kg. Echocardiography 
revealed mild concentric left ventricular hypertrophy, regional wall motion defect in left 
anterior descending territory (LAD Tx), and impaired systolic function with an ejection 
fraction of 40%. His coronary angiogram was done through transfemoral approach after 
proper consent revealing critical lesion with 90% stenosis in mid left anterior descending 
(LAD) artery just after large diagonal branch, normal left circumflex territory, and right 
coronary artery (Fig. 1, 2). The coronary angiogram was completed using 9 mL of contrast. 
The contrast used was iodixanol which is an iso-osmolar contrast agent. Percutaneous 
coronary intervention (PCI) was planned subsequently. Intravenous heparin (100 U/Kg) was 
administered. Based on all the baseline factors, it was a high risk PCI carrying a profound 
risk of CIN. To minimize the risk of CIN, intravenous normal saline infusion was started. Pri-
or to PCI, initial angiogram with same angle of projection was uploaded to the monitor for 
PCI guidance. Left main artery was engaged with 6F extra backup guiding catheter (EBU; 
Medtronic, USA) which was confirmed by entry of the runthrough wire (Terumo, Japan) into 
the coronary artery. An exaggerated curve was created to facilitate the wiring of LAD. 
Additional runthrough wire was placed in first diagonal branch (D1) based on the previous 
angiogram (Fig.3B). The side branch wire served as an important landmark to guide PCI and 
to protect the side branches as well. The balloon was positioned just after D1 which was used 
as a landmark for proximal end for stent placement. Lesion was gradually predilated with 
2x10 and 2.5x10 pantera leo semi compliant balloons (Biotronik, Germany). 3x23 mm 
Endeavour Resolute (Zotarolimus eluting stent; Medtronic, USA) stent was positioned across 
the lesion keeping the proximal end at the crossing of LAD and D1 wire which was serving 
as the origin of D1 (Fig. 3B). It was deployed at 13 atm pressure (Fig. 4). As it was not fully 
expanded, it was serially post dilated by 3x10 and 3.5x10 non-compliant Minitrak balloon 
(Abott, USA) at 24 atm pressure. The stent apposition was checked under stent boost. After 
confirmation of stent optimization with stent boost, final angiography with 4 ml contrast 
injection revealed successful results (Fig. 5). Therefore, PCI was completed using 13 ml of 
contrast. He was clinically stable for 2 days without CIN (Serum creatinine 3.5 mg/dL). She 
was discharged 2 days after PCI with appropriate drugs and has been uneventful.  
 
Discussion 
CKD and CAD share several risk factors, and therefore patients with CKD have a higher 
atherosclerotic burden [5]. Presence of advanced atherosclerosis is also major risk factors for 
CIN, thus complicating PCI in patients with CKD and thereby making revascularization an 
under-utilized option in this subset of patients. These patients who undergo revascularization 
have survival advantage over medical therapy alone based on observational studies although 
randomized trials are lacking [5]. However, concern regarding CIN and requirement of RRT 
offsets the performance of revascularization in patients with CKD. Pre-existent renal disease 
is the strongest independent predictor for development of CIN and the requirement for RRT, 
which develop in 27 and 4% of patients with severe CKD, respectively. The 2014 European 
Society of Cardiology/European Association for Cardio-Thoracic Surgery (ESC/EACTS) 
guidelines on myocardial revascularization advocate ad hoc rather than staged PCI in patients 
with CKD and extensive atherosclerosis, if substantial contrast use in one single invasive 
procedure can be avoided, to minimize the risk of acute kidney injury secondary to 
atheroembolism [6]. Despite many proposed modality to treat CIN, prevention is the best 
strategy to improve the outcome after PCI as in-hospital, 1-year, and 5-year mortality rate are 
significantly higher in patients who develops CIN compared to those who don’t (1.4% vs. 
22%), (3.7% vs. 12.1%), and (14.5% vs. 44.6%) respectively [7]. Contrast volume as 
minimum as possible is the safest and most reliable strategy which can be done in several 
ways including pre-interventional imaging to plan procedure, images of target vessel anatomy 
as reference, use of diluted contrast, iso-osmolar contrast, imaging modalities such as 
intravascular ultrasound (IVUS), and hybrid imaging [7]. IVUS guided PCI has 3-fold lower 
usage of contrast compared to angiography-only approach, thus making it an attractive 
alternative imaging tool to guide PCI [7]. The drawback is that it is costlier, requires operator 
expertise, a learning curve, and accurate image interpretation which make it potentially not 
very attractive. Furthermore fluoroscopy time, the number of cine runs, or radiation dose may 
be higher for less experienced operators though it was not reported in study by Mariani J Jr et 
al [8]. IVUS carries an advantage that it gives valuable information on cross-sectional 
anatomy, appropriate landing zone, diameter and length of stent, and accurate apposition 
which therefore minimizes the complications. Although in our case, lesion was type A, 
considering the baseline profile of the patient, risk of CIN was very high which made it an 
extremely high risk procedure. In our case, minimal dosage of contrast at the end of the 
procedure was used to confirm any injuries in the form of dissection, apposition, and status of 
side branch. Therefore, it was demonstrated that ultra-low contrast volume reduces the rate of 
CIN in patients with chronic renal disease who undergo PCI, which can be done with limited 
resources where IVUS is not available. The lack of worsening renal function following PCI 
in our case suggests that CIN is the major cause of acute nephropathy following 
revascularization, and staged procedure may be considered as an alternative in extremely 
high-risk group of patients.  
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Figure legend 
Figure 1. Left anterior descending (LAD) artery revealing critical lesion with 90% stenosis in 
mid just after large diagonal branch (D1), and normal left circumflex artery. (A — Antero-
posterior view with caudal angulation; B — Antero-posterior view with cranial angulation) 
Figure 2. Left anterior oblique view showing normal flowing right coronary artery 
Figure 3. Basal angiographic view of left system used as anatomical reference to mark 
position of LAD and D1 (A); 3x23 mm Endeavour Resolute stent was positioned across the 
lesion keeping the proximal end at the crossing of LAD and D1 wires which was serving as 
the origin of D1 
Figure 4. Stent was deployed at 13 atm pressure 
Figure 5. Final angiography with 4 mL contrast injection revealed successful PCI of LAD 
with TIMI III flow 





